83 related articles for article (PubMed ID: 1415621)
1. Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil.
Sutera SP; Chang K; Marvel J; Williamson JR
Am J Physiol; 1992 Sep; 263(3 Pt 2):H945-50. PubMed ID: 1415621
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
3. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
[TBL] [Abstract][Full Text] [Related]
4. Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil.
Tilton RG; Chang K; Weigel C; Eades D; Sherman WR; Kilo C; Williamson JR
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):861-8. PubMed ID: 3372163
[TBL] [Abstract][Full Text] [Related]
5. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
6. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
[TBL] [Abstract][Full Text] [Related]
7. Increased sciatic nerve blood flow in diabetic rats: assessment by "molecular" vs. particulate microspheres.
Chang K; Ido Y; LeJeune W; Williamson JR; Tilton RG
Am J Physiol; 1997 Jul; 273(1 Pt 1):E164-73. PubMed ID: 9252493
[TBL] [Abstract][Full Text] [Related]
8. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
9. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
Mauer SM; Steffes MW; Azar S; Brown DM
Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
[TBL] [Abstract][Full Text] [Related]
10. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
[TBL] [Abstract][Full Text] [Related]
11. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.
Williamson JR; Chang K; Tilton RG; Prater C; Jeffrey JR; Weigel C; Sherman WR; Eades DM; Kilo C
Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058
[TBL] [Abstract][Full Text] [Related]
12. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.
Sellers DJ; Chess-Williams R
J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546
[TBL] [Abstract][Full Text] [Related]
13. The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats.
Sellers DJ; Chess-Williams R
J Auton Pharmacol; 2000 Feb; 20(1):15-22. PubMed ID: 11048957
[TBL] [Abstract][Full Text] [Related]
14. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus.
McCormack AJ; Hak LJ; Finn WF
Ren Fail; 1991; 13(4):267-74. PubMed ID: 1780495
[TBL] [Abstract][Full Text] [Related]
15. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
[TBL] [Abstract][Full Text] [Related]
16. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
Robison WG; Laver NM; Jacot JL; Glover JP
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
[TBL] [Abstract][Full Text] [Related]
17. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
Akita M; Mizuno K; Matsubara A; Nakano K; Kurono M
Acta Med Okayama; 1993 Oct; 47(5):299-304. PubMed ID: 8273453
[TBL] [Abstract][Full Text] [Related]
18. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
[TBL] [Abstract][Full Text] [Related]
19. Blunted effect of ANP on hematocrit and plasma volume in streptozotocin-induced diabetes mellitus in rats.
Valentin JP; Sechi LA; Humphreys MH
Am J Physiol; 1994 Feb; 266(2 Pt 2):R584-91. PubMed ID: 8141419
[TBL] [Abstract][Full Text] [Related]
20. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.
Pugliese G; Tilton RG; Speedy A; Santarelli E; Eades DM; Province MA; Kilo C; Sherman WR; Williamson JR
Diabetes; 1990 Mar; 39(3):312-22. PubMed ID: 2307293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]